Alexion Pharmaceuticals Inc (NASDAQ:ALXN) - Share price

Stock Report

Alexion Pharmaceuticals Inc ALXN

Compound Annual Growth Rates
Revenue Growth
Year over Year43.9916.5818.4315.1516.34
3-Year Average41.8031.9325.7416.7116.63
5-Year Average42.0136.9331.5325.6421.64
Operating Income
Year over Year61.66-25.5016.221.3998.33
3-Year Average55.3514.5911.86-4.2532.71
5-Year Average60.1135.2726.5512.1422.99
Earnings per share
Year over Year156.69-79.45162.6911.93-82.23
3-Year Average53.01-19.4111.49-15.46-19.46
5-Year Average14.875.2014.109.01-22.72
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.